Question 1

How many institutions own BRVE stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BRVE shares is N/A, representing N/A of the company's common stock.

Question 2

Who are the major shareholders selling Braveheart Bio, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in BRVE by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the BRVE shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned BRVE shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying BRVE stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in BRVE by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of BRVE to its portfolio, raising its holding to - shares of worth -. N/A also increased its BRVE shares holding by N/A which brought its holding to - shares worth -.

Question 4

BRVE's major insiders: who are they?

Accepted Answer

The insider with the most stakes in BRVE is N/A , N/A at the company. Additionally, BRVE stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell BRVE stock?

Accepted Answer

Company executives, directors, and other insiders own N/A percent of Braveheart Bio, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which BRVE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased BRVE stock?

Accepted Answer

There have been 10 transaction(s) during the past 6-months in which Braveheart Bio, Inc. insiders have bought stock, totalling 3581941 shares

Question 7

How much of BRVE does insiders own?

Accepted Answer

Around 25.96M Braveheart Bio, Inc. shares are held by insiders, which represents about N/A of BRVE stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

BRVE N/A, N/A holds the largest portfolio of the company's shares. BRVE shares owned by N/A total nearly -.

Question 9

Which institution holds the most shares in BRVE?

Accepted Answer

N/A is the largest institutional owner in BRVE which holds - shares worth - or N/A of the total BRVE shares outstanding followed by N/A with ownership of - shares representing N/A of the BRVE ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Braveheart Bio, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BRVE is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on BRVE's shares?

Accepted Answer

Number of BRVE shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding BRVE shares are there?

Accepted Answer

As of today, N/A shares of BRVE are outstanding.

Question 13

Is there many float in BRVE stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BRVE has N/A shares in float.

Question 14

BRVE short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BRVE is N/A.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 07, 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A.	PURCHASE	18.00	1.68M	30.24M	10.19M
Aug 07, 2026	RICKEY JAMES PAUL	PURCHASE	18.00	27.78K	499.99K	520.93K
Aug 07, 2026	VIEHBACHER CHRISTOPHER	PURCHASE	18.00	83.33K	1.5M	609.52K
Aug 07, 2026	MALEK DAVID I	PURCHASE	18.00	4.17K	74.99K	533.85K
Aug 07, 2026	ANDERSON MICHELE A.	PURCHASE	18.00	1.11K	20K	332.16K
Aug 07, 2026	MURDOCH TRAVIS	PURCHASE	18.00	83.33K	1.5M	2.94M
Aug 07, 2026	LUBNER DAVID CHARLES	PURCHASE	18.00	55.56K	999.99K	55.56K
Aug 07, 2026	AH BIO FUND IV, L.P.	PURCHASE	18.00	1.1M	19.8M	10.23M
Aug 07, 2026	CHIMOVITS EREZ	PURCHASE	18.00	273.33K	4.92M	273.33K
Aug 07, 2026	ORBIMED ADVISORS LLC	PURCHASE	18.00	273.33K	4.92M	273.33K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 07, 2026	FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A.	PURCHASE	18.00	1.68M	30.24M	10.19M
Aug 07, 2026	RICKEY JAMES PAUL	PURCHASE	18.00	27.78K	499.99K	520.93K
Aug 07, 2026	VIEHBACHER CHRISTOPHER	PURCHASE	18.00	83.33K	1.5M	609.52K
Aug 07, 2026	MALEK DAVID I	PURCHASE	18.00	4.17K	74.99K	533.85K
Aug 07, 2026	ANDERSON MICHELE A.	PURCHASE	18.00	1.11K	20K	332.16K
Aug 07, 2026	MURDOCH TRAVIS	PURCHASE	18.00	83.33K	1.5M	2.94M
Aug 07, 2026	LUBNER DAVID CHARLES	PURCHASE	18.00	55.56K	999.99K	55.56K
Aug 07, 2026	AH BIO FUND IV, L.P.	PURCHASE	18.00	1.1M	19.8M	10.23M
Aug 07, 2026	CHIMOVITS EREZ	PURCHASE	18.00	273.33K	4.92M	273.33K
Aug 07, 2026	ORBIMED ADVISORS LLC	PURCHASE	18.00	273.33K	4.92M	273.33K

BRVE Stock Ownership Breakdown

Braveheart Bio

Stock Outstanding Shares

Institutional Ownership

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions

Stock Outstanding Shares

Institutional Ownership

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions